HO

About

Hotgen engages in research, develops, and manufactures medical and public safety inspection products. It is a diagnostic technology platform that develops and expands liquid biopsy early screening technology for cancer and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation. Their technology deploys antibody drugs, live bacteria drugs, exosome drugs, and other biopharmaceutical fields and creates a development strategy for the entire industry chain, from diagnosis to treatment.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 9 investors are based in Daxing, Beijing, China.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

ho••••@hotgen.com.cn
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Hotgen

Search Investors